Revolution Medicines, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.30 |
11.91 |
13.88 |
171.32 |
664.15 |
1,455.75 |
| Przychód Δ r/r |
0.00% |
3869.70% |
16.56% |
1134.21% |
287.67% |
119.19% |
| Przychód (min) |
0.30 |
11.91 |
13.88 |
171.32 |
664.15 |
1,455.75 |
| Przychód (max) |
0.30 |
11.91 |
13.88 |
171.32 |
664.15 |
1,455.75 |
| EBITDA (średnia) |
-0.18 |
-7.15 |
-8.33 |
-102.79 |
-398.49 |
-873.45 |
| EBIT (średnia) |
-0.18 |
-7.15 |
-8.33 |
-102.79 |
-398.49 |
-873.45 |
| EBIT % |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
| Zysk netto (średni) |
-614.22 |
-787.38 |
-949.91 |
-809.58 |
-393.01 |
217.54 |
| Zysk netto % |
-204740.04% |
-6611.55% |
-6843.34% |
-472.56% |
-59.18% |
14.94% |
| EPS (średnia) |
-3.47 |
-4.69 |
-5.01 |
-4.52 |
-2.34 |
1.30 |
| Liczba analityków (Przychody) |
7 |
7 |
10 |
9 |
3 |
4 |
| Liczba analityków (EPS) |
12 |
10 |
10 |
8 |
7 |
6 |
| symbol |
RVMD |
RVMD |
RVMD |
RVMD |
RVMD |
RVMD |